RecruitingPhase 3

Citicoline as Neuroprotector in Neonates Exposed to Hypoxia

Egypt40 participantsStarted 2019-02-01

Plain-language summary

Citicoline as neuroprotector in neonates exposed to hypoxia: A randomized controlled trial

Age range1 Month

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * neonates with hypoxia. Exclusion Criteria: * hypoxic ischemic encephalopathy

number of seizures

Timeframe: 6 months

NCT IDNCT03949049

SponsorSherief Abd-Elsalam

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2029-12-01

sherief abd-elsalam, ass. prof.